Example: Heart Attack

Search clinical trials for: Brewer's Yeast

Total 60 results

NCT03207516

Completed

Sourdough Bakery Products and Digestive Function

Conditions: Dyspepsia
NCT00977587

Withdrawn

Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction

Conditions: Irritable Bowel Syndrome; Post Infective Bowel Dysfunction
NCT02859493

Terminated

Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis

Conditions: Candidiasis, Vulvovaginal
NCT02345096

Terminated

Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

Conditions: Vulvo-vaginal Candidiasis
NCT01613456

Completed

Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome

Conditions: Irritable Bowel Syndrome
NCT02990260

Completed

Effect of Saccharomyces Cerevisiae in LDL Cholesterol

Conditions: Dyslipidemias
NCT03150212

Completed

Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype

Conditions: Constipation-predominant Irritable Bowel Syndrome
NCT00924092

Completed

An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...

Conditions: Prostate Cancer; Breast Cancer; Lung Cancer; Colorectal Cancer; Head and Neck Cancer
NCT03574844

Completed

Effect of Oral Probiotic Yeast on the Composition of the Vaginal Microbiota in Healthy Women

Conditions: Vaginal Health
NCT00145093

Completed

Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2
NCT02898922

Completed

Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China

Conditions: Hepatitis B Vaccines
NCT01856920

Active, not recruiting

QUILT-3.006 for Recurrent Medullary Thyroid Cancer

Conditions: Medullary Thyroid Cancer (MTC)
NCT00978718

Completed

Selenium in Preventing Prostate Cancer

Conditions: Prostate Cancer
NCT00655161

Completed

A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation

Conditions: NSCLC
NCT01779505

Completed

A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GS-4774 (GI-13020) at Various Dose Levels and Regimens in Healthy Adults

Conditions: Healthy Volunteers
NCT01519817

Completed

Cancer Vaccine Targeting Brachyury Protein in Tumors

Conditions: Neoplasms; Malignant Solid Tumors; Colon Neoplasms; Adenocarcinoma
NCT03051399

Completed

Clinical Evaluation of the Effects of EpiCor on Digestive Comfort

Conditions: Constipation; Gastrointestinal Discomfort
NCT02764671

Unknown status

Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates

Conditions: Hepatitis; Hepatitis B; Liver Diseases; Digestive System Diseases
NCT01564134

Completed

Dose of Hepatitis B Vaccines in Non/Low-response Populations

Conditions: Vaccination; Complications, Reaction, Serum
NCT00837135

Withdrawn

GI-4000 With Adoptive Transfer in Pancreatic Cancer

Conditions: Pancreatic Cancer
NCT03710200

Completed

Breads Made With Triticum Heritage Varieties: Effect on Post-prandial Glycemia and Insulinemia

Conditions: Dietary Modification
NCT02997059

Terminated

Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease.

Conditions: Crohn's Disease Aggravated
NCT00124215

Completed

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection

Conditions: Hepatitis C
NCT00300950

Completed

Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer

Conditions: Pancreas Cancer
NCT00606086

Completed

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

Conditions: Genotype 1 Chronic Hepatitis C